companydata.dkcompanydata.dk

Afyx Therapeutics A/S: Financial statements 2021

CVR: 38793594

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Afyx Therapeutics A/S (CVR 38793594) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,509,144 and a net result of DKK -814,180 compared with DKK -1,506,650 the year before. Equity in the 2021 report amounted to DKK 6,242,847. The solvency ratio was 63.9%. The company had 2 employees in the financial year.

Gross Profit
DKK 1,509,144
Profit/Loss
DKK -814,180
Equity
DKK 6,242,847
Total Assets
DKK 9,776,239
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.5M-814K6.2M2
2020--586K-1.5M4.7M2
2019--1.1M-1.6M1M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Afyx Therapeutics A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Richard Henry Poulsen joins Afyx Therapeutics A/S as directorOct 7, 2021

As of October 7, 2021, Richard Henry Poulsen is registered as director of Afyx Therapeutics A/S.

Søren Anker Nielsen joins Afyx Therapeutics A/S as adm. dir.Oct 7, 2021

As of October 7, 2021, Søren Anker Nielsen is registered as adm. dir. of Afyx Therapeutics A/S.

Richard Henry Poulsen steps down as adm. dir. of Afyx Therapeutics A/SOct 6, 2021

As of October 6, 2021, Richard Henry Poulsen has stepped down as adm. dir. of Afyx Therapeutics A/S.

Afyx Therapeutics A/S: The 2020 annual report is outMay 6, 2021

Afyx Therapeutics A/S has published its annual report for 2020. Gross profit came to DKK -585,934, and the net result was DKK -1,506,650.

About Afyx Therapeutics A/S

Afyx Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Inphena A/S and Inphena ApS. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Capital ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 23,138,320 and a net result of DKK 1,518,132 compared with DKK -3,810,585 the year before. Equity in the 2025 report amounted to DKK 36,178,254.

Source: annual report 2025, Danish Business Authority

Other financial years